URVI PATEL: Open Payments
NPI 1265656185 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 104 payments from 26 companies in 2025. Trend: 2023 $1,452 · 2024 $2,397 · 2025 $2,358
Food & beverage: $2,358
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 14 | $267 |
| Lilly USA, LLC | 15 | $256 |
| Novo Nordisk Inc | 12 | $247 |
| Corcept Therapeutics | 7 | $187 |
| SANOFI-AVENTIS U.S. LLC | 8 | $184 |
| CeQur Corporation | 1 | $182 |
| Amphastar Pharmaceuticals, Inc. | 6 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $107 |
| Amneal Pharmaceuticals LLC | 4 | $92 |
| Madrigal Pharmaceuticals | 5 | $90 |
Products named: JARDIANCE, RECORLEV, Korlym, Ozempic, TZIELD, CeQur Simplicity, Kerendia, UNITHROID.
Industry payments across MD — which companies pay providers there.
